Advancing Global Health
Gilead recognizes that the development of innovative medicines for life-threatening diseases is only one aspect of improving public health. We also invest in programs that promote prevention, strengthen healthcare infrastructure, and provide education and financial support to the most vulnerable communities around the world.
By enabling access to medicines, challenging assumptions, fighting stigma and collaborating with partners worldwide, we work not simply to treat some of the world’s most challenging public health threats – but to eliminate them.
Expanding Treatment Access in Low- and Middle-Income Countries
Gilead is committed to meeting with public health officials, doctors and patients around the world to understand barriers and opportunities to help people access treatment for HIV, viral hepatitis and visceral leishmaniasis (VL).
Gilead Sciences and the WHO Tackle VL in Southeast Asia
Visceral leishmaniasis (VL) is a parasitic disease. An estimated 50,000 to 90,000 new cases occur worldwide each year, but it is estimated that only 25-45% of those cases are reported. VL is almost always fatal if untreated. We are collaborating with the World Health Organization (WHO) to provide AmBisome® free of charge to all patients diagnosed with the disease.
*AmBisome has not been approved in China yet.
Helping Eliminate Chronic Hepatitis C Worldwide
The WHO has set the goal of eliminating viral hepatitis worldwide by 2030. Through awareness, screening and care, we’re helping governments, patients and payers in efforts to eliminate the chronic hepatitis C virus (HCV) and end the disease. In China, we have continued to support nationwide charitable screenings and free consultations to enhance public awareness and promote China's hepatitis prevention and treatment plan.
Gilead Rainbow Grants
The Gilead Rainbow Grants Program is dedicated to supporting and improving care for people living with HIV and communities that have been affected by the epidemic. Since 2019, our program has funded dozens of projects focused on care, education and public awareness. This includes providing support through academic exchanges, hosting disease educational lectures, promoting U=U (undetectable = untransmittable), delivering psychological care and more.
Keeping Girls and Young Women HIV-Free in Sub-Saharan Countries
The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women. Through a partnership with the United States President’s Emergency Plan for AIDS Relief (PEPFAR), Gilead and other partnering organizations aim to reduce HIV among adolescent girls and young women in 10 sub-Saharan African countries.